DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Brunmark C, Runstrom A, Ohlsson L et al.
The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis.
J Neuroimmunol 2002;
130: 163-172
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.